MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA

人类白血病 16 号染色体倒转的分子发病机制

基本信息

项目摘要

A pericentric chromosome 16 inversion, inv(16)(p13;q22), is present in almost 100% of patients with the M4Eo subtype of acute myeloid leukemia. A fusion gene between CBFB, the gene for a subunit of transcription factor CBF/PEBP2, and MYH11, which codes for smooth muscle myosin heavy chain, is generated by this chromosome 16 inversion. This fusion gene is believed to play a key role in leukemogenesis. We recapitulated this fusion gene in mice by inserting a human MYH11 cDNA into mouse Cbfb gene by homologous recombination. Chimeric mice lacked contribution of ES cells with the fusion gene to hematopoietic tissues selectively, suggesting a toxic effect of the fusion gene to hematopoiesis. Embryos heterozygous for the fusion gene had defects in both primitive and definitive hematopoiesis and died in midgestation due to widespread CNS hemorrhages. The phenotype is suggestive of a mechanism by which the chimeric protein Cbfb-SMMHC, coded by the fusion gene Cbfb-MYH11, dominantly interferes with transcriptional regulation by CBF as well as one or more additional pathways important for hematopoiesis. The phenotype of hematopoiesis blockage is consistent with the potential of this fusion gene to contribute to leukemogenesis. We are designing experiments to understand the underlying mechanisms and to bypass the embryonic lethality in order to observe the effects of this fusion gene in adult mice. To understand how Cbfb-SMMHC interferes with transcriptional regulation by CBF and other proteins, we have started to analysis its effect on DNA binding by Cbfa and ETS, another transcription factor important for hematopoiesis. Bacterial and insect viral vectors have been constructed or obtained from our collaborator Nancy Speck for the expression of the proteins. Proteins have been purified and used in assays for DNA-protein bindings. Preliminary results indicate that Cbfb-SMMHC has some effect on the cooperative interaction between Cbf and Ets. Further studies are in progress to confirm this finding and to extend to in vivo assays for the detection of any functional differences.
16号染色体臂间倒位inv(16)(p13; q22)存在于 几乎100%的急性髓性白血病M4Eo亚型患者。 CBFB与转录亚基基因之间的融合基因 因子CBF/PEBP 2和MYH 11,其编码平滑肌肌球蛋白重 链,是由16号染色体倒位产生的。这种融合基因是 被认为在白血病发生中起着关键作用。 我们在小鼠中通过插入人MYH 11 cDNA来重现该融合基因, 通过同源重组导入小鼠Cbfb基因。嵌合小鼠缺乏 融合基因ES细胞对造血组织的贡献 选择性,表明融合基因的毒性作用, 造血融合基因杂合的胚胎具有缺陷, 原始和最终的造血,并在妊娠中期死亡,原因是 导致中枢神经系统广泛受损表型暗示了一种机制 该融合基因编码的嵌合蛋白Cbfb-SMMHC Cbfb-MYH11,主要干扰CBF的转录调控 以及一个或多个对造血重要的额外途径。 造血阻滞的表型与潜能相符 这种融合基因的突变导致了白血病的发生我们正在设计 实验,以了解潜在的机制,并绕过 胚胎致死率,以观察该融合基因的作用 在成年小鼠中。 了解Cbfb-SMMHC如何干扰转录调控 通过CBF和其他蛋白质,我们已经开始分析它对DNA的影响, 通过Cbfa和ETS结合,另一种对 造血细菌和昆虫病毒载体已经构建 或者从我们的合作者南希·斯派克那里获得的, proteins.蛋白质已被纯化并用于DNA-蛋白质分析。 绑定。初步结果表明,Cbfb-SMMHC具有一定的作用 Cbf和Ets之间的合作互动。进一步的研究 正在进行中以证实这一发现,并扩展到体内测定, 任何功能差异的检测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

P P LIU其他文献

P P LIU的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('P P LIU', 18)}}的其他基金

MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA
人类白血病 16 号染色体倒转的分子发病机制
  • 批准号:
    6162550
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DESIGN AND CONSTRUCTION OF HUMAN ARTIFICIAL CHROMOSOME VECTORS
人类人工染色体载体的设计和构建
  • 批准号:
    2576538
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC ANALYSIS OF ZEBRAFISH EMBRYO DEVELOPMENT
斑马鱼胚胎发育的遗传分析
  • 批准号:
    6162609
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DESIGN AND CONSTRUCTION OF HUMAN ARTIFICIAL CHROMOSOME VECTORS
人类人工染色体载体的设计和构建
  • 批准号:
    5203422
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MEFV GENE STUDY USING TRANSGENIC MOUSE MODELS
使用转基因小鼠模型进行 MEFV 基因研究
  • 批准号:
    6162608
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
DESIGN AND CONSTRUCTION OF HUMAN ARTIFICIAL CHROMOSOME VECTORS
人类人工染色体载体的设计和构建
  • 批准号:
    6162551
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR PATHOGENESIS OF CHROMOSOME 16 INVERSION IN HUMAN LEUKEMIA
人类白血病 16 号染色体倒转的分子发病机制
  • 批准号:
    5203420
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Prevention of Radiation-Induced Carcinogenesis by Senolytics
通过 Senolytics 预防辐射诱发的致癌作用
  • 批准号:
    23H03539
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Elucidation of Prostaglandin D Receptor-mediated Carcinogenesis Mechanism of Colitic Cancer
前列腺素D受体介导的结肠癌致癌机制的阐明
  • 批准号:
    23K08219
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
  • 批准号:
    23K05734
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
  • 批准号:
    23K15977
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interactions Between the Microbiota and Helicobacter pylori in Gastric Carcinogenesis
微生物群与幽门螺杆菌在胃癌发生中的相互作用
  • 批准号:
    10709135
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Pathways of Injury and Repair in Barrett's Carcinogenesis
巴雷特癌发生过程中的损伤和修复途径
  • 批准号:
    10713938
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Spatial transcriptomic research on carcinogenesis and progression of lung cancer with interstitial pneumonia
肺癌合并间质性肺炎发生发展的空间转录组学研究
  • 批准号:
    23K14468
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
TWINNING FOR EXCELLENCE TO STRATEGICALLY ADVANCE RESEARCH IN CARCINOGENESIS AND CANCER
结对卓越,战略性地推进致癌和癌症研究
  • 批准号:
    10050740
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
骨髓细胞驱动胰腺可塑性和致癌机制
  • 批准号:
    10607213
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Stromal contributions to breast carcinogenesis
基质对乳腺癌发生的贡献
  • 批准号:
    10748124
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了